Clinical Data Cuts FY2010 Loss as Revenues Rise 26 Percent

Despite increased spending, its full-year net loss dropped sharply due to last year's charge of $55.1 million for purchased in-process R&D.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories